Literature DB >> 11872189

Do over-the-counter medications for migraine hinder the physician?

Thais Brown Tonore1, Deborah S King, Sara L Noble.   

Abstract

The availability of many over-the-counter drugs that were formerly prescription medications enable patients with migraine to self-medicate easily and delay entry into the appropriate medical management. The potential for adverse effects, drug interactions, and analgesic rebound headaches can often be complications that hinder treatment. Over-the-counter products force the patient to employ a less effective step-care approach as opposed to evidence-based guidelines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872189     DOI: 10.1007/s11916-002-0014-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  23 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Cost-effectiveness of sumatriptan in a managed care population.

Authors:  R F Legg; D A Sclar; N L Nemec; J Tarnai; J I Mackowiak
Journal:  Am J Manag Care       Date:  1997-01       Impact factor: 2.229

Review 3.  Feverfew for preventing migraine.

Authors:  M H Pittler; B K Vogler; E Ernst
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 4.  The burden of migraine. A review of cost to society.

Authors:  R B Lipton; W F Stewart; M Von Korff
Journal:  Pharmacoeconomics       Date:  1994-09       Impact factor: 4.981

5.  Migraine diagnosis and treatment: results from the American Migraine Study II.

Authors:  R B Lipton; S Diamond; M Reed; M L Diamond; W F Stewart
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

6.  The outcome of treating patients with suspected rebound headache.

Authors:  J S Warner
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

Review 7.  Transformed migraine, analgesic rebound, and other chronic daily headaches.

Authors:  N T Mathew
Journal:  Neurol Clin       Date:  1997-02       Impact factor: 3.806

Review 8.  Role and impact of over-the-counter medications in the management of headache.

Authors:  F D Sheftell
Journal:  Neurol Clin       Date:  1997-02       Impact factor: 3.806

9.  Efficacy of feverfew as prophylactic treatment of migraine.

Authors:  E S Johnson; N P Kadam; D M Hylands; P J Hylands
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-31

10.  Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.

Authors:  J J Murphy; S Heptinstall; J R Mitchell
Journal:  Lancet       Date:  1988-07-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.